$CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Stock
$celz
2015 Form 10-K Financial Statement
#000107878216002633 Filed on April 14, 2016
Income Statement
| Concept | 2015 |
|---|---|
| Revenue | $0.00 |
| YoY Change | |
| Cost Of Revenue | |
| YoY Change | |
| Gross Profit | |
| YoY Change | |
| Gross Profit Margin | |
| Selling, General & Admin | $20.83K |
| YoY Change | 4.15% |
| % of Gross Profit | |
| Research & Development | |
| YoY Change | |
| % of Gross Profit | |
| Depreciation & Amortization | |
| YoY Change | |
| % of Gross Profit | |
| Operating Expenses | $20.83K |
| YoY Change | 4.15% |
| Operating Profit | |
| YoY Change | |
| Interest Expense | -$9.930K |
| YoY Change | -0.7% |
| % of Operating Profit | |
| Other Income/Expense, Net | |
| YoY Change | |
| Pretax Income | -$30.76K |
| YoY Change | 2.53% |
| Income Tax | $0.00 |
| % Of Pretax Income | |
| Net Earnings | -$30.76K |
| YoY Change | 2.53% |
| Net Earnings / Revenue | |
| Basic Earnings Per Share | |
| Diluted Earnings Per Share | -$254.6K |
| COMMON SHARES | |
| Basic Shares Outstanding | 18.11M shares |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2015 |
|---|---|
| SHORT-TERM ASSETS | |
| Cash & Short-Term Investments | $100.00 |
| YoY Change | |
| Cash & Equivalents | |
| Short-Term Investments | |
| Other Short-Term Assets | |
| YoY Change | |
| Inventory | |
| Prepaid Expenses | |
| Receivables | |
| Other Receivables | |
| Total Short-Term Assets | $49.60K |
| YoY Change | |
| LONG-TERM ASSETS | |
| Property, Plant & Equipment | |
| YoY Change | |
| Goodwill | |
| YoY Change | |
| Intangibles | |
| YoY Change | |
| Long-Term Investments | |
| YoY Change | |
| Other Assets | |
| YoY Change | |
| Total Long-Term Assets | $0.00 |
| YoY Change | |
| TOTAL ASSETS | |
| Total Short-Term Assets | $49.60K |
| Total Long-Term Assets | $0.00 |
| Total Assets | $49.60K |
| YoY Change | |
| SHORT-TERM LIABILITIES | |
| YoY Change | |
| Accounts Payable | $0.00 |
| YoY Change | -100.0% |
| Accrued Expenses | $0.00 |
| YoY Change | |
| Deferred Revenue | |
| YoY Change | |
| Short-Term Debt | $100.00 |
| YoY Change | -99.93% |
| Long-Term Debt Due | |
| YoY Change | |
| Total Short-Term Liabilities | $100.00 |
| YoY Change | -99.93% |
| LONG-TERM LIABILITIES | |
| Long-Term Debt | $0.00 |
| YoY Change | |
| Other Long-Term Liabilities | |
| YoY Change | |
| Total Long-Term Liabilities | $0.00 |
| YoY Change | |
| TOTAL LIABILITIES | |
| Total Short-Term Liabilities | $100.00 |
| Total Long-Term Liabilities | $0.00 |
| Total Liabilities | $100.00 |
| YoY Change | -99.93% |
| SHAREHOLDERS EQUITY | |
| Retained Earnings | |
| YoY Change | |
| Common Stock | |
| YoY Change | |
| Preferred Stock | |
| YoY Change | |
| Treasury Stock (at cost) | |
| YoY Change | |
| Treasury Stock Shares | |
| Shareholders Equity | $49.50K |
| YoY Change | |
| Total Liabilities & Shareholders Equity | $49.60K |
| YoY Change |
Cashflow Statement
| Concept | 2015 |
|---|---|
| OPERATING ACTIVITIES | |
| Net Income | -$30.76K |
| YoY Change | 2.53% |
| Depreciation, Depletion And Amortization | |
| YoY Change | |
| Cash From Operating Activities | -$14.64K |
| YoY Change | -26.8% |
| INVESTING ACTIVITIES | |
| Capital Expenditures | |
| YoY Change | |
| Acquisitions | |
| YoY Change | |
| Other Investing Activities | $0.00 |
| YoY Change | |
| Cash From Investing Activities | $0.00 |
| YoY Change | |
| FINANCING ACTIVITIES | |
| Cash Dividend Paid | |
| YoY Change | |
| Common Stock Issuance & Retirement, Net | |
| YoY Change | |
| Debt Paid & Issued, Net | |
| YoY Change | |
| Cash From Financing Activities | 13.90K |
| YoY Change | -30.5% |
| NET CHANGE | |
| Cash From Operating Activities | -14.64K |
| Cash From Investing Activities | 0.000 |
| Cash From Financing Activities | 13.90K |
| Net Change In Cash | -740.0 |
| YoY Change | |
| FREE CASH FLOW | |
| Cash From Operating Activities | -$14.64K |
| Capital Expenditures | |
| Free Cash Flow | |
| YoY Change |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2015 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
18113750 | shares |
